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Accepted 14 June 2019Peroxisomes are essential for lipid metabolism and disruption of liver peroxisomal function results in neonatal
death. Little is known about how peroxisomal content and activity respond to changes in the lipid environment
in human skeletal muscle (HSkM).
Aims:Wehypothesized and tested that increasedperoxisomal gene/protein expression and functionality occur in
HSkM as an adaptive response to lipid oversupply.
Materials andmethods:HSkMbiopsies, derived from a total of sixty-two subjects, were collected for 1) examining
correlations between peroxisomal proteins and intramyocellular lipid content (IMLC) as well as between perox-
isomal functionality and IMLC, 2) assessing peroxisomal gene expression in response to acute- or 7-day high fat
meal (HFM), and in human tissue derived primary myotubes for 3) treating with high fatty acids to induce per-
oxisomal adaptions. IMLC were measured by both biochemical analyses and fluorescent staining. Peroxisomal
membrane protein PMP70 and biogenesis gene (PEX) expression were assessed using western blotting and
realtime qRT-PCR respectively. 1-14C radiolabeled lignocerate and palmitate oxidation assays were performed
for peroxisomal and mitochondrial functionality respectively.
Results: 1)Under fasting conditions, HSkM tissue demonstrated a significant correlation (P≪ 0.05) between IMCL
and the peroxisomal biogenesis factor 19 (PEX19) protein as well as between lipid content and palmitate and
lignocerate complete oxidation. 2) Similarly, post-HFM, additional PEX genes (Pex19, PEX11A, and PEX5) were
significantly (P ≪ 0.05) upregulated. 3) Increments in PMP70, carnitine octanoyl transferase (CrOT), PGC-1α,
and ERRα mRNA were observed post-fatty acid incubation in HSkM cells. PMP70 protein was significantly (P ≪
0.05) elevated 48-h post lipid treatment.
Conclusions: These results are the first to associate IMLCwith peroxisomal gene/protein expression and function
in HSkM suggesting an adaptive role for peroxisomes in lipid metabolism in this tissue.







Disparate opinions exist regarding mitochondrial lipid oxidation in
the obese and diabetic state. Thus, there is still debate as to whether
skeletal muscle mitochondrial fatty acid oxidation (FAO) rates are di-
minished [1,2], unchanged [3,4] or even increased with obesity [5].
However, it is well accepted that lipid metabolism is dysregulated in
human skeletalmuscle (HSkM) as evidenced by ectopic lipid accumula-
tion which has been associated with insulin resistance [5]. Further,y, Physiology, Surgery and the
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possess reduced mitochondrial content and alterations in morphology
[6]. This has encouraged researchers to focus on extra-mitochondrial
factors that may be involved in lipidmetabolism, such as pathways reg-
ulating lipid catabolism and trafficking [7]. However, an important fac-
tor that has largely been overlooked with respect to maintaining a
healthy cellular lipid environment in skeletal muscle is the peroxisome.
Themajority of our understanding of peroxisomal function has been
derived from studies in hepatic tissue fromanimals [8],whereas the role
of peroxisomes in maintaining lipid homeostasis in extra-hepatic tis-
sues is less well understood. The early identification of peroxisomal
function in humans was realized from the study of genetic diseases
such as X-linked adrenoleukodystrophy [9]. Moreover, peroxisomes
are indispensable for specific catabolic and anabolic reactions in lipidthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ersity from ClinicalKey.com by Elsevier on April 21, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
54 T.-Y. Huang et al. / Metabolism Clinical and Experimental 98 (2019) 53–61metabolism inmammals and can be found inmost human tissues, espe-
cially in liver. For example, they are also involved in catabolizing other
dietary fatty acids such as β-oxidation of long-chain fatty acids (LCFA)
and very-long-chain fatty acids (VLCFA). Other aspects of lipid metabo-
lism in hepatic tissue include synthesis of ether phospholipids and bile
acids [10]. Previous studies indicted increases in PMP70, and other
PEXs genes via PPARα expression following high fat diets in rodent he-
patocytes [11,12]. It is still largely understudied regarding the potential
contribution(s) for peroxisomes in lipid metabolism of human skeletal
muscle. To our knowledge, reports are rare describing a peroxisomal
presence in skeletal muscle tissue, and these come from studies in ro-
dents [13–15] and one recent report in human primary myotubes [16].
It is well established that mitochondrial entry of fatty acids for full oxi-
dation is mainly mediated by mitochondrial carnitine palmitoyltransferase
1 (CPT1) [17,18]. Our laboratory previously reported that CPT1 activitywas
reducedwith obesity [1].We have subsequently reported that peroxisomal
activity and peroxisomal oxidation of very-long-chain fatty acid (VLCFA;
e.g., C-24 lignocerate which must undergo peroxisomal partial β-
oxidation prior to complete oxidation by mitochondria) was significantly
elevated in skeletal muscle from obese fatty Zucker (fa/fa) rats containing
high IMLC compared to lean counterparts [13].
The involvement of peroxisomal FAOmay be especially crucial for cel-
lular lipid homeostasis in obesity whenmuscle CPT1 activity is decreased
[1]. In this regard, a more recent investigation utilizing a muscle-specific
CPT1β knock-out mouse has shown that impaired mitochondrial fat oxi-
dation induced peroxisomal β-oxidation to compensate for reductions in
mitochondrial lipid disposal [14]. Despite these observations suggesting
that peroxisomal FAO activity and conferred functional interactions with
mitochondria might be crucial in FAO, studies describing cooperation be-
tween peroxisomes and mitochondria are nearly non-existent in HSkM.
Therefore, the purpose of the present study was to determine if peroxi-
somal gene and protein expression regulating biogenesis/activity occurs
under conditions of elevated IMLC in HSkM. The present findings are
thefirst to report a peroxisomal presence inHSkMtissue that is associated
with elevations in IMLC. Results support and encourage future research to
determine whether peroxisomesmay serve as a viable therapeutic target
for enhancing skeletal muscle FAO in an effort to reduce the prevalence
andmetabolic consequences associated with high intramyocellular lipids
as noted with obesity and Type 2 Diabetes [1,19,20].
2. Research design and methods
2.1. Human subjects
Subjects were recruited from the Greenville area of North Carolina.
Inclusion criteria for the study were non-obese/lean (BMI ≤26 kg/m2),
obese (BMI ≥30 kg/m2), non-diabetic (fasting glucose ≪110 mg/dl),
and pre-menopausal, sedentary female subjects between the ages of
18–45 years. Individuals reported no recent history of substantial
weight loss or gain [(±2 kg for the previous 12 months), hypertension,
metabolic and/or musculoskeletal diseases (not taking prescribedmed-
ications for metabolic diseases). All procedures were approved by the
East Carolina University Institutional Review Board.
2.2. Materials
Radiolabeled [1-14C] palmitatewas purchased fromPerkinElmer (Bos-
ton MA), and [1-14C] lignoceric acid was obtained from American
Radiolabeled Chemicals (St. Louis, MO). Primary cell culture reagents
and plates were purchase from Invitrogen, as described previously [16].
All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
2.3. High fat meal/diet intervention
The dietary phase of the study was divided into two phases as fol-
lows: A) High Fat Meal: On day 1, subjects reported to the laboratoryDownloaded for Anonymous User (n/a) at East Carolina Univ
For personal use only. No other uses without permissionfollowing a 10 h, overnight fast. A blood sample was obtained from an
antecubital vein to determine fasting glucose and insulin to confirm
non-insulin resistance and diabetic status (i.e., HOMA-IR) [21] and sex
steroids (estradiol and progesterone) to confirm subjects were in the
early follicular phase of the menstrual cycle [22] using a Synchron Ac-
cess Clinical System, UniCel DxC600i, (Beckman-Coulter, Brea, CA). A
vastus lateralis muscle biopsy was taken pre- and 4 h-post- high fat liq-
uid meal of Pulmocare (Abbott Laboratories, Columbus, OH) and heavy
cream (50% daily caloric requirements; ~70% calories from fat: SAT:
MUFA:PUFA= 48:37:15). B) High Fat Diet (HFD): Subjects were subse-
quently placed on a HFD composed of 60% fat, 20% carbohydrate, and
20% protein over the remaining day following the second biopsy and
4 h post liquid meal. The subjects consumed a solid food HFD at
~40 kcal/kg body weight/day and were asked to keep a food consump-
tion log for seven days. The diet components were provided by the
study staff based on individual food preferences. The structured solid
food diet was designed to reproduce the typical “Western Diet” with a
lipid composition of 48% SFA, 15% PUFA, and 37% MUFA. On day 7, the
third and final muscle biopsy and blood samples were obtained as on
the day 1 visit.2.4. Triacylglycerol assay (TAG)
Tomeasure intramyocellular lipid content and for correlational anal-
yses with functional measurements, we employed the method
established and validated in our laboratory [16]. A commercial triglycer-
ide assay (SIGMA, CAT. # TR0100) was used to measure glycerol as the
indirect measure of total triglycerides in the muscle extracts.2.5. BODIPY (493/503) dye
BODIPY was used to visualize intramuscular lipid droplets. BODIPY
(Life Technologies, Eugene, OR) assays were conducted to confirm dif-
ferences in intramyocellular lipid content (mainly lipid droplets) and
to correlate with PEX19 and palmitic and lignocerate oxidation. The
staining and quantification procedure was based on previous publica-
tions [23–25]. Briefly, frozen human skeletal muscle was sectioned at
10 μm using a cryostat, mounted on slides (two cryosections per
slide), rapidly fixed in ice-cold 4% paraformaldehyde solution for 1 h,
and then rinsed with phosphate buffered solution (PBS) for 3 × 5 min.
The sections were immersed in 10 μg/ml BODIPY working solution
using Coplin jars for 30 min. Subsequently, the sections were rinsed in
PBS 5 × 5min, coveredwith coverslips using Vectashieldmountingme-
dium (Burlingame, CA) and sealedwith transparent nail polish. Fluores-
cent images were captured with an optical microscope (Leica DM6000,
Germany) through a 20× objective. A laser was used to excite BODIPY
493/503. Imaging settings were kept constant for all slides. Quantifica-
tion of lipid droplets was performed using multi measurement plugin
of ImageJ with a constant threshold to compare the fluorescent signal
between subjects. Individual muscle fibers were manually delineated
and measured.2.6. Human skeletal muscle cell culture
Satellite cells were isolated from 50 to 80mg of fresh muscle tissues
from vastus lateralis and cultured into myotubes as previously de-
scribed [16] and validated [26] in our laboratory. All assays were done
using myoblasts of passage 4 or less. Regarding high fatty acid treat-
ment, on day 5 of differentiation, mature myotubes were treated with
differentiation media supplemented with 1% bovine serum albumin
(control) or a mixture of 500 μM palmitate:oleate (1:1 ratio; 250 μM
each) bound to 1% BSA + 1 mM carnitine (i.e., high fatty acid incuba-
tion) for 48 h (for protein measures) or for 12 h (for mRNA measures).ersity from ClinicalKey.com by Elsevier on April 21, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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Western blotting assays were performed using PAGE-SDS proce-
dures after whole cell homogenization/tissue extraction and BCA assays
for total protein as described previously [16]. All information of primary
and secondary antibodies was also described in previously published
work [8].2.8. RNA extraction and mRNA expression quantification
RNA extraction and mRNA expression quantification were per-
formed as described previously [16]. Briefly, total RNA was isolated
from human primary myotubes and HSkM tissues with RNeasy plus
mini kit (Qiagen) and TRIzol reagent respectively. The extraction proce-
dureswere based onmanufacturer's instructions. 2 μg RNAwere used to
perform the reverse transcription reaction. Subsequent qRT-PCR was
performed with ViiA™ 7 Real-Time PCR System (Applied Biosystems,
Carlsbad, CA) using TaqMan Gene expression assay for Estrogen related
receptor α (ERRα; Hs00607062_gH). All the other gene expression re-
agents were described in previous published work from our laboratory
[16]. mRNA expression was determined using the comparative Ct
method with an endogenous control (18S ribosomal RNA) and con-
verted to a linear function by using a base 2 antilog transformation.2.9. Long-chain (LCFA) and very-long-chain fatty acid (VLCFA) oxidations
Whole tissue homogenization and FAO assays were preformed
according to our established methods [1,13,16]. Briefly, 40–100 mg
muscle from vastus lateralis were quickly homogenized and kept
on ice until oxidation experiments were performed. Our experi-
ments employed [1-14C] palmitate ± etomoxir (a CPT1 inhibitor at
100 μM) to examine fatty acid oxidation by peroxisomes and mito-
chondria, and [1-14C] lignoceric acid (C24:0) to evaluate the
influence of peroxisomal β-oxidation on oxidation capacity of mito-
chondria (lignoceric acid cannot be oxidized by the mitochondrion
directly and requires a peroxisomal presence). Data were expressed
as picomole (lignoceric acid) or nanomole (palmitate) of substrate
oxidized per gram tissue wet weight per hour as published earlier
by laboratory [16].Table 1
Subject profiles.











Age (years) 34.5 ± 2.3 32.0 ± 2.4 25.0 ± 1.8 34.7 ± 2.8⁎ 30.8 ±
Height (cm) 166.7 ± 1.5 165.0 ± 1.2 165.5 ± 1.8 164.6 ± 3.0 169.5 ±
Weight (kg) 65.3 ± 1.9 107.7 ± 3.1⁎⁎ 61.7 ± 4.2 93.5 ± 6.6⁎⁎ 71.9 ±
BMI (km/m2) 23.5 ± 0.6 39.6 ± 1.2⁎⁎ 22.6 ± 1.5 34.6 ± 2.7⁎⁎ 25.1 ±
Body fat (%) 37.7 ± 1.8 50.7 ± 1.0⁎⁎ 33.8 ± 2.3 42.9 ± 1.8⁎ 41.6 ±
Fasting glucose
(mg/dL)
89.5 ± 1.4 90.9 ± 2.4 88.8 ± 5.2 94.8 ± 7.5 90.7 ±
Insulin (μIU/mL) 5.8 ± 0.7 18.9 ± 8.6 7.6 ±
HOMA-IR 1.3 ± 0.2 4.9 ± 2.3 1.7 ±
E2 (pM) 338.4 ± 99.6 325.1 ± 136.1 348.5 ±
P4 (nM) 3.1 ± 0.6 1.5 ± 0.3 2.3 ±
Triglyceride
(mg/dL)
93.2 ± 21.3 98.6 ± 8.0 75.7 ± 12.7 106.6 ± 20.4 74.3 ±
VO2max
(ml/kg/min)
20.3 ± 1.7 15.0 ± 0.6 32.3 ± 1.9 31.3 ± 0.0 28.9 ±
Data are mean ± SEM. Abbreviations: BMI: body mass index; HOMA-IR: homeostasis model a
⁎ P b 0.05 vs. lean group within each figure.
⁎⁎ P b 0.001 vs. lean group within each figure.
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To examine relationships between serum TG, IMLC, and specific var-
iables, Pearson Product Moment Correlation and linear regression anal-
yses were used. Paired t-test was used to compare data from pre- and
post-fat treatment (4-h HFM or 7-day HFD). Repeated measures
ANOVA was used to examine group differences of the data in terms of
interactions of body composition (lean vs. obese) × environmental
stimulus (control vs. 4-h HFM/7-day HFD or fatty acid-treatment).
Post hoc analyses were performed as appropriate. Statistical analyses
were performed using SPSS Statistics for Windows version 20.0 (IBM,
Armonk, NY). All group data collected are presented as means ± SEM,
and an α-level for statistical significance was set a priori at P ≤ 0.05.
3. Results
3.1. Subject profiles (Table 1)
Groups delineated as lean and obese are described for each figure.
Collectively, results indicated that the lean/non-obese individuals had
BMIs ≦25 kg/m2 and obese subjects had BMIs ranging from 35 to
50 kg/m2 indicating that target goals were obtained. Lean subjects
were non-insulin resistant as defined by HOMA-IR obtained from
fasting glucose and insulin measurements (non-insulin resistance:
HOMA-IR ≪ 3.0). All subjects had fasting glucose levels ≪100 mg/dl
and were non-diabetic. Furthermore, subjects were in the early follicu-
lar phase of their menstrual cycle as indicated by fasting estradiol and
progesterone values and were sedentary but healthy as established by
activity questionnaire responses and VO2 peak measurements (15–32
ml/kg/min).
3.2. Correlations of serum triacylglycerides (TAG) and intramyocellular
lipid content (IMLC) and peroxisomal biogenesis factor 19 (Pex19)
To determine if a relationship exists between IMLC (i.e., TAG/lipid
droplets) and peroxisomal biogenesis in HSkM, muscle lipid content
was quantified by TAG and BODIPY staining assays and were correlated
with PEX19 from human biopsies in the pre-high fat meal and post-7d
diet protocol conditions. The gene PEX19 encodes a protein involved
in early peroxisomal biogenesis, which acts both as a cytosolic chaper-











4.1 36.4 ± 3.8 29.0 ± 2.5 37.0 ± 4.7 27.7 ± 2.9 33.5 ± 3.6
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ssessment for insulin resistance; E2: estradiol; P4: progesterone.
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Fig. 1. Intramyocellular lipid is significantly correlatedwith peroxisomal biogenesis factor 19 (PEX19) protein inhuman skeletalmuscle. TAGassay, BODIPY staining, andwestern blotwere
performed to quantify the neutral lipid and PEX19 content respectively in human skeletal muscle tissue extracts in the pre-high fat meal and post-7d diet protocol conditions. Results are
shown as a scatter plot of paired variables and regression analysis (A) Serum TG and PEX19 (n= 21) (B) IMTG and PEX19 (n= 21), (C) lipid droplets and PEX19 (n= 18), (D) western
blots for PEX19 protein and α-tubulin (loading control); data are mean ± SEM expressed as arbitrary units, (E) BODIPY: high lipid and low lipid droplets.
56 T.-Y. Huang et al. / Metabolism Clinical and Experimental 98 (2019) 53–61[27]. The amount of PEX19 protein was significantly, positively corre-
lated to serumTAG level (Fig. 1A) (r=0.42, P=0.05) and to IMTG con-
tent (Fig. 1B) (r = 0.47, P = 0.02). To further demonstrate the
association between lipid and PEX19, BODIPY staining was used to his-
tochemically quantify and to visualize neutral lipid from HSkM (Fig. 1C
& E). Similarly, lipid droplet fluorescence and PEX19 protein amount
was also significantly correlated (r = 0.67, P = 0.002) (Fig. 1C). How-
ever, PEX19 protein content was not significantly different between
the lean and obese subjects (Fig. 1D).
3.3. Peroxisomal-mitochondrial fatty acid oxidation is significantly corre-
lated with IMLC in HSkM
To test whether IMLC is associated with peroxisomal activity, we
performed BODIPY staining for lipid droplets using HSkM tissue cryo-
sections obtained pre-high fat meal. A significant correlation (r =Downloaded for Anonymous User (n/a) at East Carolina Univ
For personal use only. No other uses without permission0.70; P=0.01) was demonstrated between lipid droplets and complete
palmitate oxidation (Fig. 2A), palmitate oxidation in the presence of
etomoxir (r = 0.65, P = 0.02) (Fig. 2B) and lignocerate oxidation (r =
0.63, P = 0.02) (Fig. 2C).
3.4. Lipid overload (high fat meal/high fat diet; HFM/HFD) induces peroxi-
somal biogenesis gene expression
To test whether acute lipid overload can induce themRNA of perox-
isomal biogenesis genes, an experimental design was employed on Day
1 of the study utilizing a single HFM with 70% of calories from dietary
fat. The 70-kDa peroxisomal membrane protein (PMP70) is a peroxi-
somal specific ATP binding cassette transporter believed to import
long chain and odd chain fatty acids into the peroxisomalmatrix for par-
tial β-oxidation [10] [28]. In response to the HFM, PMP70 gene expres-
sion was increased by 190% at 4 h post HFM (P ≤ 0.05, Fig. 3A).ersity from ClinicalKey.com by Elsevier on April 21, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
Fig. 2. Mitochondrial-peroxisomal fatty acid oxidation is significantly correlated with
intramyocellular lipid content in human skeletal muscle. Correlation between palmitate
complete oxidation as 14CO2 and lipid droplet (fluorescent intensity) (N= 12; r = 0.70;
P = 0.01) (B) palmitate (C16:0) oxidation with etomoxir and lipid droplet (N = 12; r =
0.65; P = 0.02), (C) correlation scatter plot between intramyofiber lipid droplets by
BODIPY assessment and complete lignocerate (C24:0) oxidation (N = 12; r = 0.63; P =
0.02).
57T.-Y. Huang et al. / Metabolism Clinical and Experimental 98 (2019) 53–61Furthermore, there was a significant increase in PEX19 mRNA expres-
sion (Fig. 3B) as well as PEX11AmRNA [involved in peroxisomal prolif-
eration and regulation of peroxisomal division [29], (Fig. 3C)] and PEX5
mRNA [(import receptor for peroxisomal targeting sequences contain-
ing peroxisomal matrix proteins) (Fig. 3D)] in both lean and obese sub-
jects (P ≤ 0.05).
To demonstrate whether a chronic HFD had an impact on the PEX
gene expression, we fed lean and obese subjects a high fat diet (60% ofDownloaded for Anonymous User (n/a) at East Carolina Univers
For personal use only. No other uses without permission. Ccalories) for 7 days. PMP70 gene expression was significantly up-
regulated (P b 0.05) in obese subjects (Fig. 4A). In contrast, no signifi-
cant differences in the level of PEX19 (Fig. 4B), PEX11A (Fig. 4C) or
PEX5 (Fig. 4D) mRNA expression were detected. Overall, when consid-
ering the data from both Figs. 3 and 4, it appears that except for
PMP70 in the obese state, the peroxisomal mRNA levels are only ob-
served to increase in the acute state (i.e., following a 4-hour HFM).
3.5. Peroxisomes respond to a high fatty acid treatment in human primary
myotubes
To verify whether peroxisomal genes were responsive to high fatty
acid environments, primary myotubes derived from human skeletal
muscle biopsies were incubationwith a 50:50mixture of palmitate:ole-
ate (250 μMeach) for 12 h. The established peroxisomalmarker, PMP70
[13,16], and other genes were measured by real-time RT-PCR assays.
PMP70 mRNA was 24% higher between control and lipid-treatment
groups in obese individuals (P = 0.07) (Fig. 5A). Likewise, CrOT mRNA
significantly increased in both groups (P ≪ 0.05) (Fig. 5B) in response
to lipid challenge. Additionally, PGC-1αmRNAexpressionwas increased
by 63% (P=0.08) in the obese group, but not in the lean group (Fig. 5C).
Interestingly, estrogen related receptor α (ERRα) mRNA increased sig-
nificantly (P b 0.05) in primary myotubes following 12 h high fatty
acid exposure (Fig. 5D).
3.6. PMP70 protein content is significantly elevated in human primary
myotubes after 48 h lipid incubation
Following 48-h lipid treatment, PMP70 protein content was signifi-
cantly elevated in primary myotubes derived from obese subjects (P ≪
0.05). In lean counterparts, PMP70 protein content was increased by
27% but did not reach statistical significance (P = 0.09) (Fig. 5E). This
finding demonstrates that elevations in the peroxisomal marker
PMP70 is inducible by high lipid exposure in human primarymyotubes.
4. Discussion
This is the first report suggesting a peroxisomal presence in associa-
tion with increased intramuscular lipid content (IMLC) in human skele-
tal muscle (HSkM). Our major findings were 1) peroxisomal gene and
membrane protein levels are responsive to environmental stimuli
(lipid overload) in HSkM following an acute HFM and a more chronic
HFD in vivo or an acute, high fatty acid exposure in human primary
myotubes in vitro and 2) IMLC is significantly correlated with peroxi-
somal VLCFA and LCFA oxidation [and with a condition of inhibited mi-
tochondrial fatty acid entry (CPT1) by etomoxir] in HSkM.
In the present studies, we investigated the relationship between in-
tramuscular triacylglycerol (IMTG) content and PEX19 protein content.
PEX19 is a cytosolic chaperone responsible for imparting class 1 perox-
isomal targeting signal (PTS1) proteins to the peroxisomal membrane
to confer function. Moreover, PEX19 can mediate peroxisomal mem-
brane protein formation by cooperating with other peroxins; for
example, peroxisomal biogenesis factor 16 [30,31]. To expand, in the cy-
toplasm, PEX19 is believed to mediate peroxisomal membrane protein
(PMP) assembly to facilitate peroxisomal membrane elongation at the
early stage of peroxisomal biogenesis [15]. New insights into the distri-
bution, protein abundance, and subcellular localization of the endoge-
nous peroxisomal biogenesis proteins including PEX19 in different
fiber types of the adult mouse are reported in the literature [15,32].
Therefore, it is reasonable to suggest that PEX19 protein elevations
may be linked to peroxisomal biogenesis in HSkM. However, this asso-
ciation does not establish a cause-effect relationship between IMTG/
lipid droplets and an induction of peroxisomal biogenesis or function,
with future studies still required. It is also noteworthy that we did not
observe differences between lean and obese subjects. Thus, it appears
that obesity per se does not appear to drive peroxisomal induction inity from ClinicalKey.com by Elsevier on April 21, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
Fig. 3. Peroxisomal mRNA is up-regulated in response to a high fat meal in human skeletal muscle in both lean and obese subjects. mRNA expression levels (A) PMP70, (B) PEX19,
(C) PEX11A and (D) PEX5 were significantly up-regulated 4-h post - high fat meal. mRNA expression levels were quantified using RT-PCR. Data (mean ± SEM) were normalized to
18S and then compared to the lean subjects. *P ≤ 0.05 vs. pre-HFM. ** P b 0.05 between lean and obese. HFM: high fat meal (n = 4/group).
58 T.-Y. Huang et al. / Metabolism Clinical and Experimental 98 (2019) 53–61HSkM but rather the extent of the lipid milieu, which can be quite var-
iable among both lean and obese individuals. Further studies that in-
clude lipidomic analyses along with high fat treatment to explain the
relationship between specific intramyocellular lipid species and induc-
tion of peroxisomal β-oxidation function in HSkMmay prove insightful.
Peroxisomal and mitochondrial functions are closely linked to per-
form lipid oxidation. Our laboratory demonstrated that PEX19 gene ex-
pression was elevated following PGC-1α induction of peroxisomal
activity [16]. Data also suggested that human primary myotubes with
ad-PGC-1α overexpression increased mitochondrial citrate synthesis,
Tfam, and PMP70 mRNA as well as concomitant increase in IMTG [16].
Similarly, albeit in rodents, we observed a co-induction in peroxisomal
and mitochondrial content in an obese Zucker rat (fa/fa) model [13].
Data indicated a significant elevation in mitochondrial citrate synthase inFig. 4. PMP70mRNA is up-regulated after 7 days high fat diet in human skeletalmuscle fromobe
0.05 vs. pre-HFD. ** P ˂ 0.05 between lean and obese. HFM: high fat meal. HFD: high fat diet. Da
group).
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isomal density, and functional oxidation of peroxisomal specific lignoceric
acid oxidation by peroxisomes and mitochondria. Both observations oc-
curred concomitantly with significant elevations in mitochondrial com-
plete oxidation of acyl carnitines in the obese state with higher IMLC.
Despite the clear connections, the relative contribution of peroxisomes
and mitochondria to overall oxidative flux is currently unknown.
To test whether IMLC is associated with peroxisomal activity, we
performed BODIPY staining for lipid droplets using skeletal muscle tis-
sue cryosections. A significant correlation (P ≪ 0.05) between lipid
droplets and palmitate oxidation (Fig. 2A), palmitate plus etomoxir
(CPT1 inhibitor) treatment (Fig. 2B) and lignocerate oxidation (Fig.
2C) was demonstrated. These data suggest that peroxisomes are induc-
ible in association with elevations in the lipid environment in HSkM,se subjects.mRNA levels for (A) PMP70, (B) PEX19, (C) PEX11A and (D) PEX5by RT-PCR. *P ≤
ta (mean± SEM)were normalized to 18S and then compared to the lean subjects (n= 4/
ersity from ClinicalKey.com by Elsevier on April 21, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
Fig. 5. Peroxisomal mRNA and protein responses to a high fatty acid treatment in human primary myotubes. Quantification of (A) PMP70, (B) CrOT, (C) PGC-1α, and (D) ERRα gene
expression by RT-PCR after 12 h high fat incubation on day 5 of differentiation in human primary myotubes (n = 4/group). All data were normalized to 18S. (E) PMP70 protein
content in human primary myotubes derived from lean vs. obese subjects after high fatty acid treatment for 48 h (n = 6/group). PMP70: peroxisomal membrane protein; CrOT:
carnitine octanoyl transferase; ERRα: (estrogen related receptor α). Data are presented as mean ± SEM normalized to lean controls. *P ≪ 0.05 vs. control.
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dria. Collectively, the data demonstrate that VLCFA and LCFA oxidation
by peroxisomes from HSkM homogenates is significantly correlated
with measures of lipid droplets (Fig. 2B & C, P = 0.02 and P = 0.02 re-
spectively). This supports the current hypothesis that peroxisomal
abundance is elevated concurrently with IMLC to provide an alternative
route for lipid disposal and thus compensate for an excess in the lipid
environment to reduce lipotoxicity.
A further novel aspect of the present study is the finding that a single
high fat meal (HFM) induces peroxisomal gene expression in HSkM. In-
deed, peroxisomal PEX genes were acutely up-regulated in humans
in vivo (Fig. 3). In addition to PEX 19, we observed an upregulation of
PMP70 gene expression. PMP70 is involved not only in importation of
long- and very long chain- fatty acids into the peroxisomematrix for par-
tial oxidation but is also a common marker for peroxisomal biogenesis
due to concomitant elevated expression of the PMP70 gene. For example,
Kozawa et al. [8] noted that the hepaticmRNAexpression level of Abcd2, a
subtype of ABC transporters in rodents, increases 6-fold in 20-weeks fol-
lowing a HFD fed inmice. Our studies also determined that there are two
additional peroxisomal genes, PEX11A and PEX5, which were elevated in
response to the HFM (Fig. 3C & D). Peroxisomal proteins encoded by
these two genes are also involved in peroxisomal biogenesis and mem-
brane elongation. PEX5 functions as a peroxisomal matrix protein im-
porter. Matrix proteins associated with targeting sequences PTS1 and
PTS2 can be recognized by PEX5 for peroxisomal matrix import. Caution
should be exercised at this point, however, because relative to the currentDownloaded for Anonymous User (n/a) at East Carolina Univers
For personal use only. No other uses without permission. Cpaper, the study by Kozawa et al. [8] utilized hepatic tissues and an ex-
tended dietary intervention protocol. This clearly justifies further investi-
gations in HSkM to compare findings from rodent studies.
To simulate chronic high lipid consumption typical of many individ-
uals consuming a “Western Diet”, the present studies also investigated
the effects of a 7-day HFD intervention on induction of peroxisomal
genes. Data obtained using qRT-PCR demonstrated that PMP70 mRNA
expression levels were significantly (P b 0.05) up-regulated after
7 days of a HFD in obese subjects (Fig. 4A). However, smaller changes
in PEX genes (i.e., PEX19, PEX11A, and PEX5) were non-significant (P N
0.05) in both lean and obese subjects (Fig. 4B, C, & D). Compared to
the previous literature with 20 weeks of diet intervention from Kozawa
et al. [8], the results in present study offered the possibility that the 7-
day diet would be insufficient to elicit accumulated adaptations for
PEX genes expression. Second, decreases in PEX11A and PEX5mRNA in
obese subjects suggested that a longer term of HFD would be needed
to promote PEX gene induction. It is also possible that the obese subjects
had less IMLC in the skeletal muscle based on the positive correlation
data between PEX19 and lipid content in HSkM samples obtained in
the pre-HFD status. These premises will need further investigations.
Accordingly, we utilized primary myotubes to test our hypothesis
that peroxisomal gene and protein expression are inducible in response
to elevations in the cellular lipid environment. The mRNA/gene expres-
sion data suggested that 12-h post fatty acid treatment, the peroxisomal
marker PMP70 (P = 0.07) (Fig. 5A) and the peroxisomal acylcarnitine
transporter CrOT mRNA (P ≪ 0.05) were upregulated (Fig. 5B),ity from ClinicalKey.com by Elsevier on April 21, 2020.
opyright ©2020. Elsevier Inc. All rights reserved.
60 T.-Y. Huang et al. / Metabolism Clinical and Experimental 98 (2019) 53–61presumably to facilitate lipid oxidation in response to a lipid challenge.
In the primary myotubes, PGC-1α mRNA was also noted to be elevated
following lipid incubation/overload (Fig. 5C) although statistical signif-
icance was not achieved. However, recently our group applied a gain of
function approach to demonstrate the role of PGC-1α in inducing both
peroxisomal activity and mitochondrial biogenesis [16] and induced
overexpression resulted in increased peroxisomal mRNA and lipid oxi-
dation in human derived primary myotubes.
Linked with PGC1α induction, peroxisome proliferator-activated re-
ceptors (PPARs) are transcription factors belonging to the superfamily of
nuclear receptors. Three isoforms (α, δ, and γ) have been described.
They act on DNA response elements as heterodimers with the nuclear
retinoic acid receptor. Their natural activating ligands are fatty acids and
lipid-derived substrates. PPAR-α is present in liver, heart, and, to a lesser
extent, skeletal muscle. When activated, it promotes fatty acid oxidation,
ketone body synthesis, and glucose sparing. Under the present experimen-
tal conditions PPARα mRNA was not elevated following lipid incubation
(data not shown) suggesting that the peroxisomal proliferation signaling
pathway(s) may differ in HSkM compared to other tissues such as the
liver [11,12,33]. Alternatively, it is noteworthy that ERRα gene expression
was significantly elevated (P b 0.05; Fig. 5D) following lipid incubation.
ERRαwould be a transcriptional factor partneredwith PGC1α in tissues
that rely primarily on mitochondrial oxidative metabolism for energy
production such as heart and skeletalmuscle [34–36]. As such, the pres-
ent findings suggest that ERRα may act to potentiate peroxisomal bio-
genesis and concomitant enhance the mitochondria's ability to
completely oxidize peroxisomal export products which include me-
dium chain acyl-carnitines.
In conclusion, the evidence herein suggests that peroxisomal abun-
dance by measures of mRNA, protein expression, and fatty acid, radio-
isotope activity assays are responsive to the lipid milieu. Thus, the
current study provides the first evidence for a peroxisomal presence as-
sociated with lipid oversupply and IMTG accumulation in human skele-
tal muscle which may include a peroxisomal-mitochondrial functional
cooperation regarding lipid oxidation, obesity and diabetes.Declaration of Competing Interest
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